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ABSTRACT 
 
The yeast Hsp110 chaperone Sse1 is a conserved protein that is a non-canonical member 
of the Hsp70 protein super-family. Sse1 influences the cellular response to heat stress and 
has also been implicated in playing a role in the propagation of prions in yeast. Sse1 can 
seemingly exert its effects in vivo through direct or indirect actions by influencing the 
nucleotide exchange activity of canonical cytosolic Hsp70s. Using a genetic screen based 
on the inability to propagate the yeast [PSI+] prion, we have identified thirteen new Sse1 
mutants that are predicted to alter chaperone function through a variety of different 
mechanisms. Not only are these new Sse1 mutants altered in the ability to propagate and 
cure yeast prions but also to varying degrees in the ability to grow at elevated 
temperatures. The expression levels of chaperone proteins known to influence yeast prion 
propagation are unaltered in the Sse1 mutants suggesting that the observed phenotypic 
effects are due to direct functional alterations in these mutants. Mapping the location of 
the mutants onto the Sse1 crystal structure suggests that more than one functional 
alteration in Sse1 may result in changes in prion propagation and ability to function at 
elevated temperatures. All Sse1 mutants isolated provide essential functions in the cell 
under normal growth conditions, thus further demonstrating that essential chaperone 
functions in vivo can to some degree at least be detached from those related to 
propagation of prions. Our results suggest that Sse1 can influence prion propagation 
through a variety of different mechanisms. 
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INTRODUCTION 
 
Hsp110 proteins are a group of eukaryotic molecular chaperones that have been 
implicated in a variety of cellular functions. Several cytosolic Hsp110 protein variants 
have been described in eukaryotes, including HSPH1, Apg-1, Apg-2 and Grp170 in 
mammals (VOS et al. 2008; KAMPINGA et al. 2009). Hsp110 is represented in S. 
cerevisiae by the Sse1 and Sse2 proteins. SSE1 and SSE2 constitute an essential gene pair 
in yeast (TROTT et al. 2005) and while not essential in itself deletion of SSE1 does confer 
a growth defect and stress-related phenotypes (SHIRAYAMA et al. 1993; SHANER et al. 
2004; SHANER et al. 2008). Sse1 was first isolated from yeast biochemically as a 
calmodulin-binding protein (MUKAI et al. 1993) and genetically as a suppressor of a 
protein kinase A (PKA) mutant (SHIRAYAMA et al. 1993). Sse1 and Sse2 share a high 
degree of sequence identity (~76%) and are non-canonical members of the Hsp70 
superfamily (MUKAI et al. 1993). SSE1 is expressed at moderately high levels under 
normal growth conditions and is further induced upon heat shock while SSE2 transcripts 
are nearly undetectable at basal temperatures but are increased more than 20-fold upon 
heat shock (MUKAI et al. 1993; SHIRAYAMA et al. 1993).  
The Sse1 protein has been crystallized and established to be modular, built-up 
from Hsp70-like subdomains (LIU and HENDRICKSON 2007). Even though Sse1 and 
canonical Hsp70 have diverged in function, certain structural features in Hsp70 have 
been conserved in Sse1. Mutational analysis revealed that particular mutant variants of 
Sse1 and Ssa1 (one of the major yeast cytosolic Hsp70s) result in similar phenotypic 
defects, supporting the hypothesis that Sse1 is an evolutionary vestige of Hsp70 (LIU and 
HENDRICKSON 2007). It has been reported that Sse1, like Ssa1, can recognize and bind 
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hydrophobic peptide sequences with high affinity (GOECKELER et al. 2008) and can 
exhibit ATPase activity (RAVIOL et al. 2006a; RAVIOL et al. 2006b). However, the 
functional similarities end there, as Sse1 cannot functionally refold denatured proteins but 
instead acts as a ‘holdase’ by binding denatured proteins and preventing their aggregation 
(OH et al. 1999). This ‘holdase’ function may serve a function in the peptide-refolding 
pathway carried out by other chaperones. Various Hsp110 homologs have been shown to 
accelerate the refolding of luciferase by Hsp70/Hsp40 machinery (GOECKELER et al. 
2002). 
Although specific intracellular functions of Hsp110 proteins are poorly 
characterized in comparison to various canonical Hsp70s, it has been suggested recently 
that they may act as the principal nucleotide exchange factor (NEF) for Hsp70. Sse1 was 
shown to act as a potent NEF for yeast cytosolic Hsp70 proteins Ssa1 and Ssa2 
(DRAGOVIC et al. 2006; RAVIOL et al. 2006b). This discovery followed soon after the 
discovery that Hsp110 proteins physically and functionally interact with their Hsp70-Ssa 
counterparts (YAMAGISHI et al. 2004; SHANER et al. 2005; YAM et al. 2005). Prior to 
these findings Fes1 was the only identified NEF for Ssa1 (KABANI et al. 2002a). The 
regulation of substrate binding by ATP hydrolysis and subsequent nucleotide exchange is 
a key component in maintaining correct in vivo function for all Hsp70 chaperones. 
The general domain organization of Sse1 does reflect that of canonical Hsp70s. It 
consists of a N-terminal nucleotide-binding domain (NBD), a β-sandwich domain (SBD-
β) and a three helical bundle domain (3HBD or SBD-α) towards the C-terminus. The 
Sse1 protein has a compact structure with tight interactions between the NBD and 
substrate-binding domain (SBD). Unlike Hsp70, the Sse1 SBD-α does not form a lid over 
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its binding pocket but instead interacts with the flank of the Sse1 NBD (POLIER et al. 
2008). Sse1 is larger than Hsp70 due to insertions within the SBD and a C-terminal 
extension (EASTON et al. 2000; LIU and HENDRICKSON 2007). Sse1 shares ~30% 
sequence identity with Ssa1 (SHANER et al. 2005; YAM et al. 2005). Like other Hsp70-
Hsp110 interacting components the sequence similarity between Sse1 and Ssa1 is largely 
confined to the NBD (GOECKELER et al. 2008).  
Sse1 preferentially associates with Ssa1 in vivo (SHANER et al. 2005). The Hsp70 
NBD is embraced by the NBD and SBD-α of Sse1 leading to the opening of the Hsp70 
nucleotide-binding cleft. The Sse1 β-sandwich domain of the substrate binding cleft 
alternates away from the complex (POLIER et al. 2010). It appears that almost the entire 
length of Sse1 is required for complex formation with Hsp70 (SHANER et al. 2004; 
DRAGOVIC et al. 2006; POLIER et al. 2008). Complex formation also requires Sse1 to be 
ATP-bound as this alters the NBD structure in a way that stabilizes it and allows it to 
bind Hsp70 (SHANER et al. 2006; POLIER et al. 2008). Yeast Sse1 can also form a 
functional complex with human Hsp70, which reflects a high degree of conservation in 
the Hsp70-Hsp110 structure (SHANER et al. 2006). 
The multi-domain architecture of Sse1 suggests that it may play a role as a 
chaperone similar to Hsp70. However, the protein folding ability of canonical Hsp70s 
relies heavily on the conformational structural changes between the NBD and SBD upon 
ATP/ADP binding; such allostery appears absent in Sse1. The Sse1 substrate-binding 
pocket remains closed upon ATP binding suggesting that any potential substrate-binding 
or chaperone activity inherent in Sse1 will be functionally distinct to Hsp70 
(ANDRÉASSON et al. 2008). 
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 Since the seminal paper by WICKNER (WICKNER 1994) proposed that the yeast 
non-Mendelian genetic elements [PSI+] and [URE3] are prions of the Sup35 and Ure2 
proteins respectively, many subsequent studies have shown this proposal to be correct 
and that a significant number of other fungal proteins have prion forming ability 
(DERKATCH et al. 2001; ALBERTI et al. 2009). A variety of in vitro and in vivo studies 
have demonstrated an integral role for molecular chaperones in yeast prion propagation 
(reviewed in, JONES and TUITE 2005; TRUE 2006; PERRETT and JONES 2008; MASISON et 
al. 2009). Most chaperone/prion studies have focused upon the yeast 
Hsp40/Hsp70/Hsp104 protein disaggregation machinery (CHERNOFF et al. 1995; GLOVER 
et al. 1997; KRZEWSKA and MELKI 2006; SHORTER and LINDQUIST 2008), which has 
been shown to play an essential role in propagation of yeast prions. More recently, 
evidence has accumulated suggesting a role for yeast Hsp110 in prion formation and 
propagation. Studies have demonstrated Sse1 may be required for the de novo formation 
and propagation of [PSI+] (FAN et al. 2007; KRYNDUSHKIN and WICKNER 2007; SADLISH 
et al. 2008). Current understanding suggests that Sse1 primarily influences prion 
formation and propagation due to its NEF function for Hsp70, however, Sse1 has been 
suggested to bind to early intermediates in Sup35 prion conversion and thus facilitate 
prion seed conversion independently of its NEF function (SADLISH et al. 2008). 
Overexpressed Sse1 was shown to increase the rate of de novo [PSI+] formation while 
deleting SSE1 reduced [PSI+] prion formation; however, no effects on pre-existing [PSI+] 
was observed (FAN et al. 2007; KRYNDUSHKIN and WICKNER 2007). In contrast, the 
overproduction or deletion of SSE1 cured the [URE3] prion and mutant analysis suggests 
this activity is dependent on ATP binding and interaction with Hsp70 (KRYNDUSHKIN 
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and WICKNER 2007). Intriguingly, Sse1 has recently been shown to function as part of a 
protein disaggregation system that appears to be conserved in mammalian cells (SHORTER 
2011; DUENNWALD et al. 2012). 
 To gain further insight into the possible functional roles of Hsp110 in prion 
propagation, we have isolated an array of novel Sse1 mutations that differentially impair 
the ability to propagate [PSI+]. The locations of these mutants on the Sse1 protein 
structure suggest that impairment of prion propagation by Hsp110 can occur through a 
number of independent and distinct mechanisms. The data suggests that Sse1 can 
influence prion propagation not only indirectly through an Hsp70-dependent NEF 
activity, but also through a direct mechanism that may involve direct interaction between 
Sse1 and prion substrates. 
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MATERIALS AND METHODS 
 
Strains and plasmids: Strains and plasmids used and constructed in this study are listed 
and described in Tables 1 and 2. Site-directed mutagenesis using the Quickchange kit 
(Stratagene) and appropriate primers were used to introduce desired mutations into 
plasmids. The G600 strain, the genome of which was recently sequenced (FITZPATRICK et 
al. 2011), was used to PCR amplify SSE genes for cloning into pRS315. The human 
HSPH1 gene (alternative name HSP105) was amplified from a cDNA clone purchased 
from Origene (Rockville, MD). All plasmids constructed in this study were verified by 
sequencing. 
 
Media and genetic methods: Standard media was used throughout this study as 
previously described (GUTHRIE 1991). Monitoring of [PSI+] was carried out as described 
(JONES and MASISON 2003). Briefly, the presence of [PSI+] (the non-functional 
aggregated form of Sup35p) and SUQ5 causes efficient translation read through of the 
ochre mutation in the ade2-1 allele. Non-suppressed ade2-1 mutants are Ade- and are red 
when grown on medium containing limiting amounts of adenine due to the accumulation 
of a pigmented substrate of Ade2. Partial suppression of ade2-1 by [PSI+] allows growth 
without adenine and eliminates the pigmentation (COX 1965). 
Monitoring of [URE3] again made use of the red/white selection based on the ADE2 
gene. The strain SB34 has ADE2 under control of the DAL5 promoter. In [URE3] cells 
expression of the DAL5 promoter is high due to the action of Gln3. In [ure-0] cells 
soluble Ure2 can interact with Gln3 and prevent transcription from the DAL5 promoter. 
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Hence, when [URE3] is present the SB34 strain will grow on medium lacking adenine 
and is white on medium with limiting adenine. When [ure-0] this strain will not grow on 
medium lacking adenine and is red on medium with limiting adenine. 
 
Generation of SSE1 mutant library: Plasmid pRS315-SSE1 was subjected to treatment 
with hydroxylamine for sixty minutes (SCHATZ et al. 1988). This treatment resulted in 
mutation frequencies of around 8% for this plasmid (G. W. Jones, unpublished 
observation). 
 
Isolation of Sse1 mutants that impair [PSI+] prion propagation: Sse1 mutants were 
isolated using the plasmid shuffle technique. Strain CMY02 was transformed with the 
SSE1 mutagenized plasmid library. Transformed cells were selected on medium lacking 
leucine. Any red or dark-pink colonies were scored at this point as potential dominant 
SSE1 mutants that could weaken [PSI+]. Transformation plates were replica plated onto 
medium-containing limiting amounts of adenine and also 5-fluoro-orotic acid (5-FOA), a 
chemical that selects against URA+ cells and hence against the presence of the pRS316-
SSE1 plasmid. Colonies appearing red or dark-pink at this stage were scored as 
potentially harboring a mutant sse1 allele that cannot maintain [PSI+]. All potential sse1 
mutant containing plasmids were isolated and re-transformed back into CMY02 and 
analyzed for their effects upon [PSI+]. After re-transformation the color phenotype of 
colonies was scored subjectively from 0-9, with 0 being white and 9 being red (LOOVERS 
et al. 2007). 
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Assaying mutant effects on [URE3]: Effects on [URE3] were assayed as previously 
described (LOOVERS et al. 2007). Briefly, SB34 was grown to log phase growth under 
conditions that maintain [URE3] (medium lacking adenine). Cells were transformed with 
wild-type (WT) or mutant SSE1 alleles and transformants were selected on medium 
lacking leucine. At this stage all cells (at least 100) were scored for color phenotype on 
the basis of being white, red or sectored. 
 
Mapping mutants onto crystal structure of Sse1 and molecular modeling: Structures 
for Sse1 (2QXL, (LIU and HENDRICKSON 2007)) and for Sse1 in complex with Ssa1 
(3D2F, (POLIER et al. 2008)) were obtained from the Protein Data Bank. Molecular 
modeling to complete gap regions, introduce point mutations (100 models each), and for 
visualization was carried out using MOE (2009; ENVIRONMENT 2009.10). Images were 
generated using pyMol (DELANO 2002).  
 
Western analysis: Western analysis was performed essentially as described previously 
(JONES and MASISON 2003). Hsp70 monoclonal antibody was purchased from Cambridge 
Bioscience (SPA822), Sse1 polyclonal antibody was a gift from Jeff Brodsky (University 
of Pittsburgh) and Hsp104 polyclonal antibody was a gift from John Glover (University 
of Toronto). 
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RESULTS 
 
Isolation of novel mutants of SSE1 that impair [PSI+] prion propagation 
Applying the plasmid shuffle technique as described in MATERIALS AND METHODS we 
have identified thirteen new mutants of Sse1 that impair propagation of the [PSI+] prion 
(Figure 1, Table 3). Nine out of these mutants are located in the nucleotide-binding 
domain (NBD) and like previous studies highlight the general functional importance of 
correct ATPase regulation of Hsp70 chaperones in yeast prion propagation (JONES and 
MASISON 2003; LOOVERS et al. 2007). The mutants had a wide range of effects on 
propagation of [PSI+] with some being unable to propagate the prion at all (G41D, G50D, 
D236N, G342D, E370K and G616D) to others having minor effects on color phenotype 
(P37L, C211Y) (Table 3 and Figure 1B). The presence or absence of [PSI+] in all mutants 
was confirmed by mating with a [psi-] strain followed by sporulation of any [PSI+] 
diploids to confirm non-Mendelian segregation and subsequent growth on guanidine 
hydrochloride (GdnHCl) to cure the prion (data not shown). As expected, all Sse1 
mutants that could not propagate [PSI+] could not grow on medium lacking adenine 
(Figure 1B). However, surprisingly all other Sse1 mutants, even ones that had an 
apparently mild affect on [PSI+], also grew very poorly or not at all on medium lacking 
adenine (Figure 1B). The reason for these growth results is unknown, but perhaps 
suggests Sse1 may be involved in cellular metabolic pathways that can result in complex 
nutritional phenotypes. Significantly, none of the mutants had a major adverse effect on 
cell growth at 30oC, suggesting that each mutant is capable of carrying out the essential 
cellular functions of Sse1 (Table 3). However, at 39oC there are major differences in the 
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abilities of the mutants to grow (Table 3, Figure 1B). Deletion of SSE1 causes a 39oC 
temperature sensitive (ts) phenotype (SHANER et al. 2008) and therefore it appears that a 
subset of mutants (G50D, G342D, S440L, G616D) are effectively non-functional at this 
elevated temperature. Other mutants appear to provide either WT levels of activity 
(P37L, T365I, E554K) or some intermediate or reduced level of Sse1 functionality 
(G41D, C211Y, D236N, G343D, E370K, E504K). 
 
Effects of FES1 over-expression on the ability of Sse1 mutants to propagate [PSI+] 
Both Fes1 and Sse1 have been shown to be NEFs for cytosolic Hsp70s (KABANI et al. 
2002b; DRAGOVIC et al. 2006; RAVIOL et al. 2006b) We therefore assessed the ability of 
Fes1 to complement the prion propagation defect of this novel set of Sse1 mutants. To do 
this we carried out plasmid shuffle analysis for each Sse1 mutant in the presence of over-
expressed Fes1 (Figure 2). As a negative control plasmid shuffle analysis was also carried 
out in the presence of either pRS423 (vector only) or pRS423 harboring the CIA1 gene 
±500 bp. CIA1 is a yeast gene that has not been implicated in altering yeast prion 
propagation. Following growth on 5-FOA media also lacking histidine (to maintain 
selection for pRS423 based plasmids), cells were placed onto YPD to assess color and –
ADE –HIS medium to assess the ability to grow on medium lacking adenine. While the 
color phenotype on YPD for Sse1 WT or mutant cells harboring the vector or over-
expressing FES1 is consistent with presence of Sse1 alone (compare Figure 1B YPD 
panel with Figure 2 Control and FES1 YPD panels), the ability of some CMY02 Sse1 
mutant cells to grow on medium lacking adenine is influenced greatly by the absence of 
histidine (compare Figure 1B –ADE panel with Figure 2 Control and FES1 –ADE 
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panels). Only G616D appears altered in color on YPD by the presence of FES1 over-
expression. However this color change does not correlate with a significant increased 
ability to grow on –ADE medium (Figure 2). Comparing the effects of vector only to 
over-expressed FES1, a clear difference in ability to grow on –ADE medium is observed 
for some mutants; P37L, C211Y, S440L and E554K grow less well on –ADE in the 
presence of over-expressed FES1, while G343D and T365I grow slightly better in the 
presence of over-expressed FES1 (Figure 2). This suggests that increases in Hsp70 (Ssa) 
NEF activity are able to influence some phenotypes of this subset of Sse1 mutants. 
Currently, we have no explanation for the complex but reproducible –ADE phenotype of 
these novel Sse1 mutants shown in Figures 1B and 2. 
 
Sse1 mutants are defective in ability to cure [URE3] prion 
A previous study has highlighted the ability of over-expressed Sse1 to impair propagation 
of the yeast prion [URE3] (KRYNDUSHKIN and WICKNER 2007). Similarly we found that 
in the SB34 strain background (BACH et al. 2003) the introduction of an extra copy of 
SSE1 under control of its native promoter was capable of causing a significant 
impairment of [URE3] (Table 4). We therefore assessed the ability of the Sse1 mutants to 
impair [URE3] propagation using this assay. In contrast to WT Sse1 and in contrast to the 
diverse phenotypic effects observed in [PSI+] prion propagation and temperature 
sensitivity assays, we found that all thirteen novel Sse1 mutants were unable to 
significantly impair [URE3] propagation in the SB34 strain (Table 4). This suggests 
either a common functional change or defect within these mutants with respect to the 
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ability to cure [URE3] or that more than one functional alteration in Sse1 can impair 
[URE3] curing ability. 
 
Chaperone abundance in Sse1 mutants 
It is well documented that certain chaperones play an essential role in prion maintenance 
and alteration in expression levels can affect [PSI+] propagation (for review see (JONES 
and TUITE 2005)). We therefore measured Sse1, Hsp104 and the Hsp70 (Ssa) chaperone 
family expression levels in all the Sse1 mutants. Figure 3 (and data not shown) shows 
that no major differences in chaperone expression levels exist between any mutants 
compared to wild-type Sse1. Only the P37L mutant appeared to have slightly increased 
levels of Hsp104 and Ssa, but taking into account previous findings these are unlikely to 
be the cause of any prion or temperature-related phenotypes (JUNG et al. 2000; JONES and 
MASISON 2003; LOOVERS et al. 2007). In addition we also measured levels of Hsp70 co-
chaperones Ydj1 and Sis1 and found similar amounts of these Hsp40s within the Sse1 
mutants analyzed in Figure 3 compared to wild type (data not shown). Therefore the 
phenotypic changes in prion propagation and growth at high temperatures observed in 
these novel Sse1 mutants is most likely not due to indirect changes in chaperone 
expression levels. 
 As shown in Figure 1, a number of Sse1 mutants are unable to grow at 39ºC. One 
possible explanation for this phenotype is that such Sse1 mutants are unstable at this 
temperature. We therefore use Western blotting to assess the stability of Sse1 mutants 
following exposure to 39ºC for 1 hour and found no difference in stability between any 
Sse1 mutants compared to wild-type protein (data not shown). 
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Location of mutants on crystal structure of Sse1: functional implications 
The crystal structure of the Sse1 protein alone and in complex with cytosolic Hsp70 has 
been determined (LIU and HENDRICKSON 2007; POLIER et al. 2008; SCHUERMANN et al. 
2008). To gain insight into possible functional consequences of this new set of Sse1 
mutations we mapped mutated residues onto available Sse1 structures and used molecular 
modeling to predict possible localized structural changes and functional implications 
(Figure 4, Table 5 and Supplemental Information). Of the nine mutants identified within 
the NBD four are predicted to affect ATP binding (P37L, G342D, G343D, E370K), three 
to alter interaction with cytosolic Hsp70 (G41D, T365I, E370K) and three remain unclear 
(G50D, C211Y, D236N) (Table 5, Supplemental Information). The four mutants isolated 
in the SBD domain are predicted to alter either Sse1 interaction with cytosolic Hsp70 
(E554K, G616D, see Figure S3), substrate binding (S440L) or protein-protein 
interactions (E504K) (Table 5 and Supplemental Information). 
 
Sse2 and [PSI+] propagation 
Figure S1 shows an alignment of Sse1 and Sse2. Although these proteins share 76% 
identity, Sse2 is unable to compensate for Sse1 in terms of [PSI+] prion propagation or 
growth at higher temperatures (Figure 5, (SADLISH et al. 2008; SHANER et al. 2008). All 
but one of our novel Sse1 mutated residues is conserved in Sse2, the non-conserved 
residue corresponding to position E504 in Sse1, which is Q504 in Sse2. We reasoned that 
the inability of Sse2 to propagate [PSI+] could be influenced by this residue difference. 
Using site-directed mutagenesis we created a Q504E mutant version of Sse2 and assessed 
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the ability of this protein to propagate [PSI+]. In contrast to wild-type Sse2, Sse2Q504E is 
able to propagate [PSI+], although not to the same degree as Sse1 (Figure 5). 
Interestingly, although [PSI+] propagation is restored to some degree in Sse2Q504E, the 
ability to grow at 39ºC is not (Figure 5). In addition to rendering Sse1 unable to 
propagate [PSI+], the G616D mutation was one of two Sse1 mutants that also caused a 
37ºC ts phenotype (Figure 5 and data not shown). Similarly, when G616D is introduced 
into Sse2 the same phenotype was observed, indicating conservation of functional 
importance of this residue in these two proteins. Combining Q504E and G616D in the 
Sse2 protein produces similar phenotypes as observed for Sse1 (Figure 5) and further 
demonstrates the functional conservation between these residues within yeast Sse 
proteins. 
 
 
Functional complementation of an sse1 sse2 double deletion strain by FES1 and 
human HSPH1 is dependent on strain background 
A previous study has reported that the essential and prion- related functions of Sse1 were 
mainly related to the ability of the protein to function as a NEF for Hsp70. This was 
demonstrated by the ability of Fes1 and a N-terminally truncated Snl1 protein to 
complement the lethality of an sse1 sse2 double deletion strain(SADLISH et al. 2008). We 
therefore assessed whether Fes1 and the closest human Sse1 ortholog HSPH1, could 
propagate [PSI+] in the G600 background. We found that both Fes1 and HSPH1 were 
unable to complement essential Sse1/2 functions in the CMY02 strain (Figure 6), and 
hence we were unable to assess whether [PSI+] could be propagated. The inability of 
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Fes1 and HSPH1 to functionally substitute for deletion of sse1 and sse2 is strain specific 
as both were able to provide essential Sse1/2 functions in strain CMY03, which was 
constructed in the BY4741 background (Figure 6, Table 1). The cause of this difference 
in strain complementation is as yet unknown. 
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DISCUSSION 
 
 We have identified thirteen novel mutations in Sse1 that have varying effects on 
both the ability of S. cerevisiae to propagate the [PSI+] prion and also to grow at elevated 
temperatures. In contrast all Sse1 mutants were similarly impaired in the ability to cure 
the [URE3] prion following over-expression. The phenotypic effects of these mutants 
appear to result from functional changes in the Sse1 protein and are not due to changes in 
expression levels of other chaperones known to influence prion propagation. Given the 
varied locations of these mutants in the Sse1 molecule and their predicted structural 
effects, we provide evidence to suggest that Sse1 can influence both yeast prion 
propagation and heat shock response in a variety of ways, which are potentially direct or 
indirect in manner. 
Recently, Sse1 has been shown to play a role in the dis-aggregation of amyloid 
aggregates, including Sup35 (SHORTER 2011; RAMPELT et al. 2012). In combination with 
Hsp40 and Hsp70, Sse1 can dissolve amyloid aggregates albeit at a slower rate than 
Hsp104. Additionally, Sse1 can enhance disaggregation by Hsp104 (in the presence of 
Hsp40 and 70). This new role for Hsp110 proteins is conserved across species and 
provides the first clearly identified protein disaggregation machinery in mammalian cells 
(SHORTER 2011; DUENNWALD et al. 2012). This newly discovered biochemical activity of 
Sse1 and the fact that Sse1 appears to interact directly with Sup35 prions in vivo 
(BAGRIANTSEV et al. 2008) suggests that this chaperone may play a more direct and 
active role in modulating the propagation of yeast prions than was previously thought. 
Sse1 may influence prion propagation through influencing Ssa1 function but may also do 
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so through interacting directly with prion aggregates. The diverse range of Sse1 mutants 
we have isolated in this genetic screen and their potential functional implications (Table 5 
and Supplemental Information), supports this proposal. 
 Phenotypic analysis of the Sse1 mutants revealed sub-sets of mutants that were 
impaired to varying degrees in their ability to grow at elevated temperatures (Figure 1, 
Table 3). These results were very clear-cut and presumably are a consequence of altered 
Sse1 function due to the structural alterations. However, [PSI+] and corresponding 
adenine growth phenotypes of the mutants was very complex (Figures 1 and 2, Table 3). 
The colony color phenotype initially used for screening and assessing the presence of 
[PSI+] was very clear; that is to say, the presence or absence of [PSI+] correlated well 
with the colony color phenotype. In contrast, the ability to grow on medium lacking 
adenine did not correlate well for all the mutants. As expected those mutants shown not 
to propagate [PSI+] did not grow on –ADE medium. However, some Sse1 mutants 
confirmed as maintaining [PSI+] were also unable to grow on medium lacking adenine. 
Furthermore, the removal of histidine from the medium can influence the ability of some 
Sse1 mutants to grow in the absence of adenine and the subsequent over-expression of 
FES1 can further affect this phenotype (Figure 2). Currently, we do not have any 
explanation for this very complex but reproducible phenotype, but speculate that Sse1 
may play a role (direct or indirect) in modulating the histidine and/or adenine 
biosynthetic pathways. Both pathways are part of the “super-pathway of histidine, purine 
and pyrimidine biosynthesis” (Saccharomyces Genome Database) and converge on 
production of the biosynthetic intermediate aminoimidazole carboxamide ribonucleotide, 
accumulation of which can be toxic to the cell. If Sse1 is involved in modulating this 
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super-pathway then our mutants may be affected in the ability to synthesize either 
histidine or adenine (or both) and toxic intermediates on this pathway may also be caused 
to accumulate. The addition of histidine or adenine to growth medium would have the 
effect of switching off these pathways and therefore suppressing any impaired growth 
phenotype due to the accumulation of toxic intermediates. 
 Given the variation in the effects of mutants upon [PSI+] propagation and also 
heat shock we were surprised to discover that all the Sse1 mutants were unable to 
efficiently cure the [URE3] prion. A previous study by Kryndushkin and Wickner 
(KRYNDUSHKIN and WICKNER 2007) demonstrated that over-expression of the Sse1G223D 
mutant (reduction in Sse1 ATPase, interaction with Ssa1 and loss of Ssa1 NEF activity) 
was unable to cure [URE3] while Sse1K69M (can bind ATP but defective in hydrolysis) 
efficiently cured [URE3]. Thus it seemed that efficient Sse1 NEF activity is required to 
cure [URE3]. Our data suggests that this may be an over simplification. The clear 
phenotypic differences observed for the Sse1 mutants in respect of [PSI+] propagation 
and heat shock cannot be explained by a single unifying change in Sse1 function in all 
mutants. This suggestion is also supported by the location of the mutations on the Sse1 
structure. Therefore it appears that a variety of mechanisms that alter Sse1 function can 
alter the ability to cure [URE3]. However, it should be noted that the ability to cure 
[URE3] could be influenced by the prion variant that is present in the cells. The [URE3] 
variants present in the SB34 strain and strains used by Kryndushkin and Wickner (2007) 
(KRYNDUSHKIN and WICKNER 2007) have not been directly compared. 
 Although Sse1 and Sse2 share a high degree of amino acid sequence identity 
(Figure S1), Sse2 is unable to compensate fully for the loss of Sse1. Sse2 has previously 
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been shown to compensate for all sse1-deficient phenotypes at 30oC (SHANER et al. 2004) 
however this is not the case for [PSI+] propagation (Figure 5). In the G600 strain 
background the loss of Sse1 function causes loss of [PSI+], demonstrating a clear 
distinction in the activities of Sse1 and Sse2 at 30oC. The fact that the Sse1 mutants that 
have the greatest impairment of [PSI+] propagation are predicted to be altered in ATP 
binding and interaction with Hsp70 suggests that in vivo these activities are where Sse1 
and Sse2 will differ the most. However, of all thirteen mutated residues isolated in Sse1 
identified as altering prion propagation, only one (E504) is not conserved in Sse2 (Q504) 
(Figure S1). We reasoned that this residue contributes to the inability of Sse2 to 
propagate [PSI+]. When this residue is mutated to create Sse2Q504E [PSI+] can be 
propagated albeit not to the same extent as Sse1 (Figure 5). This result suggests that this 
residue is a key factor in dictating divergence of Sse1 and Sse2 function, and this residue 
is not predicted to alter ATP-binding or interaction with Hsp70. Hence, it appears that the 
in vivo differences in function between Sse1 and Sse2 are probably attributable to a 
number of different modifications in activity and not solely to one distinct difference. 
Clearly the interaction with Hsp70 is a key factor for in vivo function of Sse1 and Sse2 as 
demonstrated by the conserved effects of the G616D mutation (Figure 5). The combining 
of the Q504E and G616D mutation in the Sse2 protein produces similar phenotypic 
responses as for the same Sse1 variant. This indicates the functional conservation of these 
residues in yeast Sse proteins. 
The conservation of essential in vivo functions carried out by Sse1 is clearly 
shown by the ability of the closest human homolog HSPH1 to complement the growth 
phenotype of a sse1 sse2 deletion strain. A recently characterized Hsp110 ortholog from 
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Arabidopsis thaliana (AtHsp70-15) was shown to be unable to complement heat shock 
phenotypes of a sse1 deletion strain constructed in the W303 background (JUNGKUNZ et 
al. 2011). The G600 background used in this study is currently the most closely related 
sequenced laboratory strain to the original reference yeast strain S288C (FITZPATRICK et 
al. 2011) and yet there is a background-specific effect on the ability of HSPH1 to 
complement Sse defects. Hence, testing the AtHsp70-15 cDNA for complementation of 
sse deletion strains in different yeast backgrounds is certainly worth investigating and 
may demonstrate further the conservation of Hsp110 essential functions across diverse 
species. 
 The isolation of a set of new Sse1 mutants that alter yeast prion propagation has 
provided further evidence of an integral role for this chaperone in modulating the 
propagation of [PSI+] and perhaps the growing list of confirmed yeast prions. This set of 
newly characterized Sse1 mutants provides the opportunity for detailed biochemical 
assessment to address the causes of subtle differences that may exist in the functional 
alterations of Sse1 that effect activities in prion propagation as compared to other roles in 
heat shock or stress resistance. The canonical Hsp70 (Ssa) family is well characterized in 
its ability to modulate prion propagation and how this function can be distinct from roles 
in the heat shock response (JUNG et al. 2000; JONES and MASISON 2003; LOOVERS et al. 
2007). To some degree the same may be true for Sse1. 
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Figure legends 
 
Figure 1A) Sse1 mutants that impair prion propagation are located in various 
domains of the protein. Numbers above refer to amino acids that define the boundaries 
of the nucleotide-binding domain (NDB), linker region (L), substrate-binding domain 
(SBD), Hsp110 insertion region (I) and Hsp110 extension region (E). Mutants isolated 
that impair prion propagation are indicated below the linear structure. B) Phenotype of 
Sse1 mutants that impair prion propagation. Top panel shows color on YPD, middle 
panel depicts growth on medium lacking adenine and bottom panel is growth on YPD at 
39oC. 
 
Figure 2 Sse1 mutants exhibit a complex growth phenotype when grown on medium 
lacking adenine. The absence of histidine and the presence of FES1 can affect the ability 
of Sse1 mutants to grow on medium lacking adenine. Top section is growth in presence 
of either vector control or overexpression of CIA1, and bottom section is in the presence 
of over-expressed FES1. The results shown are representative of three independent 
experiments, for controls this constitutes two experiments with vector only and one with 
CIA1 overexpression. 
 
Figure 3 No change in protein levels of chaperones known to alter [PSI+] 
propagation in Sse1 mutants. Western blot analysis to measure protein levels of Sse1, 
Hsp70 (Ssa) and Hsp104. Following initial blotting using anti-Sse1 antisera, the 
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membrane was stripped and subsequently probed with Hsp104 and Hsp70 antibodies. 
Membrane was stained with amido black to show loading. 
 
Figure 4 Mapping of mutations onto Sse1 structure. A) Structural model of Sse1 
(PDB: 2QXL) with the residues of interest highlighted and in ball and stick format. 
Domains are colored to correspond to Figure 1A. Images were generated using 
Pymol(DELANO WL. 2002). 
 
Figure 5 Phenotypic analysis of yeast cells expressing Sse2 as the sole source of 
Hsp110. Growth of Sse1, Sse2 and Sse2 derived mutants on medium lacking adenine 
(top growth panels) and at elevated temperature (lower growth panels). Western blotting 
was used to assess expression levels of Sse1, Sse2 and mutants (bottom panels). 
 
Figure 6 Complementation of sse1 sse2 deletion strain by overexpression of FES1 or 
mammalian HSPH1. Growth of sse1 sse2 expressing FES1 or HSPH1 in place of SSE1 
was assessed in two strain backgrounds; CMY02 (G600 background, left section) and 
CMY03 (BY background, right section). As expected, vector only control produced no 
growth in either background. 
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TABLE 1 
Strains used in this study 
Strain name Genotype Source 
G600 MATa ade2.1 SUQ5 kar1-1 his3 leu2 trp1 ura3 
[PSI+] 
JONES et al. (2004) 
HLY100 G600 plus Δsse1 This study 
HLY101 G600 mating type switched plus Δsse2 This study 
HLY102 G600 isogenic +/Δsse1 +/Δsse2 [PSI+] diploid. 
Constructed by mating HLY100 and HLY101 
and transforming with pRS316-SSE1 
This study 
CMY02 G600 plus Δsse1 Δsse2 pRS316-SSE1, isolated 
as haploid segregant following sporulation of 
HLY102 
This study 
Y02146 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
sse1::KanMX4 
Euroscarf 
Y17167 MATα  his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
sse2::KanMX4 
Euroscarf 
CMY01 MATa/α  his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 
lys2Δ0/+ +/met15Δ0 ura3Δ0 +/sse1::KanMX4 
sse2::KanMX4/+ pRS316-SSE1 (constructed 
by mating Y02146 with Y17167 and 
transforming with pRS316-SSE1) 
This study 
CMY03 MATα  his3Δ1 leu2Δ0 lys2D0 ura3Δ0 This study 
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sse1::KanMX4 sse2::KanMX4 pRS316-SSE1 
(haploid segregant following sporulation of 
CMY01) 
SB34 MATa trp1-1 ade2-1 leu2-3,112 his3-11,15 
ura2::HIS3 erg6::TRP1 dal5::ADE2 [URE3] 
BACH et al. (2003) 
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TABLE 2 
Plasmids used in this study 
Plasmid name Description Source 
pRS315 Centromeric Saccharomyces cerevisiae 
shuttle vector- LEU2 marker 
(SIKORSKI AND HIETER 
1989) 
pRS316 Centromeric Saccharomyces cerevisiae 
shuttle vector- URA3 marker 
(SIKORSKI and HIETER 
1989) 
pRS423 2µ Saccharomyces cerevisiae high copy 
plasmid, HIS3 marker 
(CHRISTIANSON et al. 
1992) 
pC210 SSA1 under control of SSA2 promoter- 
LEU2 marker 
(SCHWIMMER and 
MASISON 2002) 
pRS315-SSE1 SSE1±500bp cloned into pRS315, LEU2 
marker 
This study 
pRS316-SSE1 SSE1±500bp cloned into pRS315, URA3 
marker 
This study 
pRS315-SSE2 SSE2±500bp cloned into pRS315, LEU2 
marker 
This study 
pRS315-SSE2Q504E Site directed mutagenesis of pRS315-
SSE2 to produce Q504E 
This study 
pRS315-SSE2G616D Site directed mutagenesis of pRS315-
SSE2 to produce G616D 
This study 
pRS315-
SSE2Q504E/G616D 
Site directed mutagenesis of pRS315-
SSE2Q504E to produce Q504E+G616D 
This study 
pRS423-FES1 FES1 ±500bp cloned into pRS423, HIS3 
marker 
(JONES et al. 2004) 
pC-HSPH1 HSPH1 under control of SSA2 promoter- 
LEU2 marker 
This study 
pRS423-CIA1 CIA1±500bp cloned into pRS423, HIS3 
marker 
This study 
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TABLE 3 
 
Relative effects of SSE1 mutants on [PSI+] prion propagation and cell growth 
 
Sse1 
mutation 
Times 
isolateda 
Color pre-
FOAb 
Color post-
FOAb 
Growth at 
39oCc 
Generation time 
(% of WT)d 
None - 0 0 +++++ 100 
P37L 1 2 3 +++++ 96 
G41D 3 3 8 ++ 100 
G50D 3 4 8 + 101 
C211Y 1 3 2 ++ 93 
D236N 1 4 9 ++ 110 
G342D 3 3 9 - 114 
G343D 1 3 4 +++ 104 
T365I 1 3 5 +++++ 104 
E370K 1 2 9 +++ 107 
S440L 1 2 6 + 97 
E504K 1 2 4 +++ 118 
E554K 2 3 4 +++++ 101 
G616D 1 2 9 - 113 
aNumber of independent times isolated in the mutant screen. 
bColor: 0, white [PSI+]; 9, Red, [psi-]; FOA, selection against presence of WT SSA1 
URA3 plasmid. 
cRelative growth after 2 days at 39oC. 
dDoubling time in minutes expressed as a % of CMY02 harboring WT SSE1. 
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Table 4 
 
Relative effects of Sse1 mutants on ability to cure [URE3] 
 
Sse1 mutation % White % Red % Sectored 
None/WT 48 13 39 
P37L 90 3 7 
G41D 96 1 3 
G50D 94 4 2 
C211Y 92 4 5 
D236N 98 1 1 
G342D 95 2 3 
G343D 84 7 9 
T365I 84 11 5 
E370K 94 2 4 
S440L 87 5 8 
E504K 87 4 9 
E554K 86 4 10 
G616D 83 4 13 
Vector only 96 2 2 
Colony color was scored subjectively as for table 1. Colony percentage is given after 
transformation of SSE1 mutant into SB34 as described in MATERIALS AND 
METHODS. 
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Table 5 
Predicted structural effects of mutants 
Mutation Location Predicted effect 
P37L β- sheet within NBD ATP binding 
G41D β- sheet within NBD Hsp70 interaction 
G50D α- helix within NBD Unclear 
C211Y β- sheet within NBD Unclear 
D236N α- helix within NBD Unclear 
G342D ATP binding pocket of NBD ATP binding 
G343D ATP binding pocket of NBD ATP binding 
T365I Loop region within NBD Hsp70 interaction 
E370K α- helix within NBD ATP binding/Hsp70 interaction 
S440L α- helix within SBDβ Substrate binding 
E504K Within insertion region of SBDβ Protein-protein interactions 
E554K α- helix within SBDα Protein-protein interactions 
G616D Loop region within SBDα Hsp70 interaction 
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